This exciting new study from ASPIRE2025 researchers Brent Caldwell and Julian Crane, is the first to look at nicotine by pMDI (pressurized metered dose inhaler) in smoking cessation.
There is growing frustration with lack of robust action and progress at the national level with the Smokefree 2025 goal. However, it is not all bad news.
E-cigarette usage is growing in NZ and around the world but the scientific evidence-base regarding the benefits and risks of these types of products remains uncertain.
Every now and then when discussing New Zealand’s Smokefree 2025 goal, plain packaging or some other policy measure, the question will come up – ‘well why don’t you just ban it?’
The recently released US Surgeon General’s report gives “sufficient” evidence of causality for 13 additional health conditions (e.g., colorectal cancer, diabetes, and stroke from secondhand smoke).